About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of our group is to investigate the use of medicines and evaluate its benefit/risk relationship in usual clinical practice. Our group coordinates the Catalan centre of the Spanish System of Pharmacovigilance. Research activities on pharmacology and pharmacoepidemiology are coupled with undergraduate teaching at the Autonomous University of Barcelona Medical School, training of specialists in clinical pharmacology, and continuous education of health professionals on therapeutics.
The group is a Special Group of Research recognized by AGAUR GenCat. It is a partner of “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” and it is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). It gives institutional support to the Clinical Research Ethical Committee of the University hospital Vall d’Hebron (UHVH), the Drug and Pharmacotherapeutic Committee of the UHVH, and also to the Drug and Pharmacotherapeutic Committee of the Institut Català de la Salut.
PMID: 35114859 Journal: ANNALS OF MEDICINE Year: 2022 Reference: Ann Med. 2022 Dec;54(1):379-392. doi: 10.1080/07853890.2021.2016940. Impact factor: Publication type: Paper in international publication Authors: Aguirre, Carmelo; Bacariza-Cortinas, Manuel; Estany-Gestal, Ana; Figueiras, Adolfo; Ibanez, Luisa; Ibarra-Garcia, Eguzkine; Macias-Garcia, Fernando; Mallah, Narmeen; Martin-Arias, Luis; Palacios-Zabalza, Itziar et al. DOI: 10.1080/07853890.2021.2016940
PMID: 35078871 Journal: BMJ case reports Year: 2022 Reference: BMJ Case Rep. 2022 Jan 25;15(1). pii: 15/1/e244581. doi: 10.1136/bcr-2021-244581. Impact factor: Publication type: Letter or abstract Authors: Anderssen-Nordahl, Emilie; Gomez Munoz, Alicia; Perello Carrascosa, Manel; Riera-Arnau, Judit et al. DOI: 10.1136/bcr-2021-244581
PMID: 35037981 Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY Year: 2022 Reference: Eur J Clin Pharmacol. 2022 Apr;78(4):691-694. doi: 10.1007/s00228-022-03277-3. Epub 2022 Jan 17. Impact factor: Publication type: Paper in international publication Authors: Alcubilla, Pau; Arellano, Ana Lucia; Belancic, Andrej; Jouanjus, Emilie; Nogueiras-Alvarez, Rita; Roncato, Rossana; Saez-Penataro, Joaquin; Sans-Pola, Carla; Zunic, Miodrag et al. DOI: 10.1007/s00228-022-03277-3
PMID: 34632668 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2022 Reference: Eur J Neurol. 2022 Feb;29(2):469-477. doi: 10.1111/ene.15137. Epub 2021 Oct 25. Impact factor: Publication type: Paper in international publication Authors: Ballarin, Elena; Berger, Ursula; Ibanez, Luisa; Maisterra, Olga; On, Begum Irmak; Sabate, Monica; San-Jose, Antonio; Vidal, Xavier et al. DOI: 10.1111/ene.15137
PMID: 33966262 Journal: Advances in respiratory medicine Year: 2021 Reference: Adv Respir Med. 2021;89(2):145-157. doi: 10.5603/ARM.a2021.0037. Impact factor: Publication type: Review in international publication Authors: Amado, Jose; Ghashut, Rawia A; Laird, Eamon; Oscanoa, Teodoro J; Romero-Ortuno, Roman; Vidal, Xavier et al. DOI: 10.5603/ARM.a2021.0037
PMID: 33135175 Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS Year: 2021 Reference: Clin Pharmacol Ther. 2021 Apr;109(4):1125-1135. doi: 10.1002/cpt.2100. Epub 2020 Dec 5. Impact factor: Publication type: Paper in international publication Authors: Aithal, Guruprasad P; Andrade, Raul J; Bjornsson, Einar; Daly, Ann K; Devarbhavi, Harshad; Eapen, Chundamannil E; Goel, Ashish; Grove, Jane I; Ibanez, Luisa; Larrey, Dominique et al. DOI: 10.1002/cpt.2100
PMID: 33010054 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2021 Reference: Br J Clin Pharmacol. 2021 Apr;87(4):2140-2145. doi: 10.1111/bcp.14582. Epub 2020 Nov 3. Impact factor: Publication type: Paper in international publication Authors: Aguilera, Cristina; Agusti, Antonia; Danes, Immaculada; Gracia, Rosa M; Perello, Manel; Perez, Eulalia; Pigrau, Carles; Sueiras, Maria et al. DOI: 10.1111/bcp.14582
PMID: 32593414 Journal: MEDICINA CLINICA Year: 2021 Reference: Med Clin (Barc). 2021 Mar 26;156(6):263-269. doi: 10.1016/j.medcli.2020.04.030. Epub 2020 Jun 24. Impact factor: Publication type: Paper in national publication Authors: Agusti, Antonia; Gost, Jordi; Laorden, Helena; Oropeza, Vanessa; Perez-Bocanegra, Carmen; Romero, Rosa; San-Jose, Antonio; Vidal, Xavier et al. DOI: 10.1016/j.medcli.2020.04.030
The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.
